Pancreatic hyperamylasemia and hyperlipasemia in association with cytomegalovirus infection following unrelated cord blood transplantation for acute myelogenous leukemia.
Cytomegalovirus (CMV)-associated pancreatitis is rare after allogeneic hematopoietic stem cell transplantation (SCT). We describe a patient who developed pancreatic hyperamylasemia and hyperlipasemia in association with CMV infection after cord blood transplantation (CBT). A 31-year-old man with acute myelogenous leukemia underwent CBT. A neutrophil count consistently greater than 500/microL was achieved on day +21. Positive results for CMV antigenemia on days +35 and +67 prompted 2 courses of preemptive therapy with ganciclovir or foscarnet. The CMV antigenemia value again became positive on day +134. On day +141, serum amylase and lipase activities markedly increased to 1221 IU/L and 894 IU/L, respectively. The patient had no abdominal symptoms. Ultrasonography and computed tomography results showed no abnormalities of the pancreas. A diagnosis of possible pancreatitis was made. After the initiation of foscarnet therapy, the CMV antigenemia results soon became negative, and serum amylase and lipase activities returned to normal. Therefore, CMV infection was considered to play a major role in the development of pancreatic hyperamylasemia and hyperlipasemia in our patient. The present report indicates that CMV infection should be included in the differential diagnosis for patients with pancreatic hyperamylasemia after SCT.
Tomonari
Akira
A
Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. atomonar@ims.u-tokyo.ac.jp
Takahashi
Satoshi
S
Takasugi
Kashiya
K
Ooi
Jun
J
Tsukada
Nobuhiro
N
Konuma
Takaaki
T
Iseki
Tohru
T
Tojo
Arinobu
A
Asano
Shigetaka
S
D000328:Adult; D000681:Amylases / Q000097:blood; D000998:Antiviral Agents / Q000008:administration & dosage; D036101:Cord Blood Stem Cell Transplantation; D003586:Cytomegalovirus Infections / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D017245:Foscarnet / Q000008:administration & dosage; D015774:Ganciclovir / Q000008:administration & dosage; D006801:Humans; D034321:Hyperamylasemia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000150:complications* / Q000628:therapy; D008297:Male; D010195:Pancreatitis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D014184:Transplantation, Homologous
D000998:Antiviral Agents; D017245:Foscarnet; D000681:Amylases; D015774:Ganciclovir